XSTELOS HOLDINGS, INC. Financial Statements (2026 and earlier)

Company Profile

Business Address 630 FIFTH AVENUE
NEW YORK, NY 10020
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2013
MRQ
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 18,112
Cash and cash equivalent 16,671
Short-term investments 1,441
Receivables 7,179
Disposal group, including discontinued operation 933
Prepaid expense and other current assets424
Assets held-for-sale 220
Other undisclosed current assets 3,956
Total current assets: 30,824
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization 1,510
Intangible asset, including goodwill, after accumulated amortization63,330
Goodwill 10,920
Intangible asset, excluding goodwill, after accumulated amortization 52,410
Restricted cash and investments 2,500
Deferred tax assets, net 20,018
Other undisclosed noncurrent assets (2,611)
Total noncurrent assets: 84,747
TOTAL ASSETS: 115,571
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 2,562
Other undisclosed accounts payable and accrued liabilities 2,562
Debt 13,311
Disposal group, including discontinued operation 773
Total current liabilities: 16,646
Noncurrent Liabilities
Liabilities, other than long-term debt, including: 35,041
Other undisclosed liabilities, other than long-term debt 35,041
Other undisclosed noncurrent liabilities 26
Total noncurrent liabilities: 35,067
Total liabilities: 51,713
Equity
Equity, attributable to parent 61,999
Common stock 24
Additional paid in capital 35,245
Retained earnings 26,730
Equity, attributable to noncontrolling interest 1,859
Total equity: 63,858
TOTAL LIABILITIES AND EQUITY: 115,571

Income Statement (P&L) ($ in thousands)

9/30/2013
TTM
12/31/2012
Revenues
(Revenue, Net)
 28,739
Gross profit: 28,739
Operating expenses (10,454)
Other operating income, net
(Other Expenses)
 800
Other undisclosed operating loss (813)
Operating income: 18,272
Nonoperating expense
(Investment Income, Nonoperating)
 (15)
Interest and debt expense (10,433)
Income from continuing operations before equity method investments, income taxes: 7,824
Other undisclosed income from continuing operations before income taxes 7,508
Income from continuing operations before income taxes: 15,332
Income tax benefit 19,671
Income from continuing operations: 35,003
Income before gain (loss) on sale of properties: 36,148
Income from discontinued operations 1,145
Net income: 36,148
Net loss attributable to noncontrolling interest (2,145)
Net income available to common stockholders, diluted: 34,003

Comprehensive Income ($ in thousands)

9/30/2013
TTM
12/31/2012
Net income: 36,148
Comprehensive income: 36,148
Comprehensive income, net of tax, attributable to noncontrolling interest 2,145
Other undisclosed comprehensive loss, net of tax, attributable to parent (4,351)
Comprehensive income, net of tax, attributable to parent: 33,942

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: